Estimated glomerular filtration rate as a predictor of secondary outcomes in Japanese patients with coronary artery disease

Journal of Cardiology

Volumn 53, Issue 2, 2009, Pages 232-239

  Matsuo, Keita ^a   Inoue, Teruo ^a   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Coronary artery disease; Estimated glomerular filtration rate; Prognosis

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK FACTORS;

EID: 62349091038     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.11.010     Document Type: Article

References (21)

1. Joki N., Hase H., Nakamura R., and Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 12 (1997) 718-723
2. Fujimoto Y., Ishiwata S., Dohi T., Masuda J., Fujimoto H., Mitani H., Maehara A., Ohno M., Yamaguchi T., Tanaka K., and Naruse Y. Long-term prognosis after coronary revascularization in patients with end-stage renal disease on dialysis: comparison of percutaneous coronary intervention and coronary artery bypass grafting. J Cardiol 50 (2007) 11-20
3. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., Halle J.P., Young J., Rashkow A., Joyce C., Nawaz S., Yusuf S., and HOPE Study Investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
4. Reddan D.N., Szczech L.A., Tuttle R.H., Shaw L.K., Jones R.H., Schwab S.J., Smith M.S., Carif R.M., Mark D.B., and Owen Jr. W.F. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. J Am Soc Nephrol 14 (2003) 2373-2380
5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 Suppl. 1 (2002) S1-S266
6. Anavekar N.S., McMurray J.J., Velazquez E.J., Solomon S.D., Kober L., Rouleau J.L., White H.D., Nordlander R., Maggioni A., Dickstein K., Zelenkofske S., Leimberger J.D., Califf R.M., and Pfeffer M.A. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
7. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
8. Muntner P., He J., Hamm L., Loria C., and Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13 (2002) 745-753
9. Manjunath G., Tighiouart H., Ibrahim H., MacLeod B., Salem D.N., Griffith J.L., Coresh J., Levey A.S., and Sarnak M.J. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41 (2003) 47-55
10. Parikh N.I., Hwang S., Larson M.G., Levy D., and Fox C.S. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study). Am J Cardiol 102 (2008) 47-53
11. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rodgers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
12. Schoebel F.C., Gradaus F., Ivens K., Heering P., Jax T.W., Grabensee B., Strauer B.E., and Leschke M. Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography. Heart 78 (1997) 337-342
13. Liu J.Y., Birkmeyer N.J., Sanders J.H., Morton J.R., Henriques H.F., Lahey S.J., Dow R.W., Maloney C., DiScipio A.W., Clough R., Leavitt B.J., and O'Connor G.T. Risks of morbidity and mortality in dialysis patients undergoing coronary artery bypass surgery. Circulation 102 (2000) 2973-2977
14. Szczech L.A., Reddan D.N., Owen W.F., Califf R., Racz M., Jones R.H., and Hannan E.L. Differential survival after coronary revascularization procedures among patients with renal insufficiency. Kidney Int 60 (2001) 292-299
15. Herzog C.A., Ma J.Z., and Collins A.J. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 106 (2002) 2207-2211
16. Henry R.M., Kostense P.J., Bos G., Dekker J.M., Nijpels G., Heine R.J., Bouter L.M., and Stehouwer C.D. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 62 (2002) 1402-1407
17. Jardine A.G. Cardiovascular complications of renal disease. Heart 86 (2001) 459-466
18. Hostetter T.H. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 351 (2004) 1344-1346
19. O'Driscoll G., Green D., and Taylor R. Simvastatin, a HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95 (1997) 1126-1131
20. Agarwal R. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Am J Physiol Renal Physiol 284 (2003) F863-F869
21. Nakamura T., Inoue T., Sugaya T., Kawagoe Y., Suzuki T., Ueda Y., Koide H., and Node K. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid binding protein levels in normotensive patients with IgA nephropathy. Am J Hypertens 20 (2007) 1195-1201